Targeted Innovation in Biliary Tract Cancer: The COMPANION-002 Trial Results on October 24, 2026 Posted by
The Recovery Paradox: Why Your Post-Workout Routine Might Be Holding You Back on October 24, 2026 Posted by
Unmasking the Invisible: New Immune Cell Discovery Offers Hope Against Aggressive Lung Cancer on October 24, 2026 Posted by
Unveiling a New Horizon in Mobility: UPnRIDE and Kessler Foundation Forge Groundbreaking Research Partnership on October 24, 2026 Posted by
Empowering the Next Generation: Active Minds Unveils the 2026-2027 Student Advisory Committee Cohort on October 24, 2026 Posted by
The New Era of Bipolar Care: How Recent Breakthroughs in Science are Redefining "Living Well" on October 24, 2026 Posted by
The Hidden Calorie Spike: Why Your Morning Coffee is Becoming Less "Black" on October 24, 2026 Posted by
Targeted Innovation in Biliary Tract Cancer: The COMPANION-002 Trial Results on October 24, 2026 Posted by
The Recovery Paradox: Why Your Post-Workout Routine Might Be Holding You Back on October 24, 2026 Posted by
Unmasking the Invisible: New Immune Cell Discovery Offers Hope Against Aggressive Lung Cancer on October 24, 2026 Posted by
Unveiling a New Horizon in Mobility: UPnRIDE and Kessler Foundation Forge Groundbreaking Research Partnership on October 24, 2026 Posted by
Posted in Digital Health Tools Breakthrough in Virology: FDA Approves Asahi Kasei’s Hovilpri for Refractory Herpes Simplex Infections on October 13, 2026
Posted in Sleep Health New Dawn for Sleep Medicine: Japan Approves WAKIX as First Non-Scheduled Treatment for Excessive Daytime Sleepiness on October 4, 2026
Posted in Medical Innovations A New Era in Pediatric Cardiology: FDA Approves First Growth-Adaptive Heart Valve on October 2, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on October 1, 2026
Posted in Digital Health Tools A New Frontier in Spinal Muscular Atrophy: FDA Approves Scholar Rock’s Isembyld on September 22, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on September 21, 2026
Posted in Medical Innovations A Breakthrough for Sanfilippo Syndrome: FDA Approves First Gene Therapy for MPS IIIA on September 18, 2026
Posted in Digital Health Tools A New Frontier in Muscle Preservation: FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy on September 14, 2026
Posted in Chronic Disease Management A New Frontier in Oncology: FDA Approves Tudriqev for Advanced Melanoma on September 14, 2026
Posted in Digital Health Tools A New Frontier in Neurology: FDA Approves Zanvastro for Rare Alexander Disease on September 12, 2026
